1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Blood and bone marrow cancers

Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma

Technology appraisal guidance [TA137] Published date: 27 February 2008

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...

Information for the public


  • Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma PDF 145.09 KB 27 February 2008  
  • Gwybodaeth i'r cyhoedd Word 238 KB 15 September 2008